A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients With Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp

• Main Authors: Eirini Kyrmanidou (Author), Christina Kemanetzi (Author), Chatzopoulos Stavros (Author), Myrto-Georgia Trakatelli (Author), Aikaterini Patsatsi (Author), Xenia Madia (Author), Dimitra Ignatiadi (Author), Evangelia Kalloniati (Author), Zoe Apalla (Author), Elizabeth Lazaridou (Author)
• Format: Book
• Published: Mattioli1885, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Psoriasis is a chronic inflammatory disease with multiple skin manifestations, and in case of lesions affecting the genital area sexual health impairment and psychological distress can furthermore impair the quality of life of patients. Secukinumab is a fully humanized antagonist of IL...